Recursion Pharmaceuticals, Inc. (RXRX) Year-over-year earnings per share growth for the last twelve months
Recursion Pharmaceuticals (RXRX) is a pioneer in synthesizing biology and neural networks, mitigating risks through strategic alliances with pharmaceutical behemoths. The quarterly EPS trajectory illustrates profit dynamics, where the current status is 39.70. However, the business relies on external contractors for conducting clinical trials and drug synthesis, creating a moderate operational dependence on third-party vendors.
Recursion Pharmaceuticals (RXRX) - metric breakdowns and financial figures
- market value and analyst target forecast:
- market capitalization details:
- book capitalization data:
- debt and solvency information:
Total Debt to Capital Recursion Pharmaceuticals|RXRX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital recursion.com|RXRX - Company Aggregate Debts|Debt to Book Capitalization Ratio Recursion Pharma|RXRX - Company Long-Term Loans and Borrowings|Company Short-Term Debt Recursion|Quick Ratio recursion.com
- earnings and valuation multiples information:
RXRX - Net Profit|Projected Future Earnings Recursion Pharmaceuticals|RXRX - Price to Earnings Ratio|Forward P/E Multiple Recursion Pharmaceuticals Inc|RXRX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Recursion Pharma|RXRX - Operating profit EBITDA|Net earnings per share for the last 12 months Recursion|RXRX - Earnings per share for the last four quarters|Quarterly EPS earnings growth recursion.com|RXRX - Expected net earnings per share growth this year|Earnings growth forecast for next year Recursion Pharmaceuticals
Initial company analysis:Recursion Pharmaceuticals
Fundamental analysis requires minimizing "value trap" risks when searching for an asset reversal. For Recursion Pharmaceuticals (RXRX), which integrates AI and biology, the cost efficiency of computing power is critical. This quarterly earnings per share growth captures the daily price action of net income, eliminating temporary gaps. This metric allows for tracking the pace of the business's profitability recovery, which protects investor capital from prolonged losses.
Who Recursion Pharmaceuticals competes with
NVIDIA (NVDA) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months CoreWeave, Inc. (CRWV)|Year-over-year earnings per share growth for the last twelve months Nebius Group N.V|Year-over-year earnings per share growth for the last 12 months SOUN (SoundHound Corp)|Year-over-year net earnings per share growth for the last 12 months ZETA (Zeta Global)|PGY (pagaya.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months C3.ai Inc AI|RZLV (Rezolve AI Limited) - Year-over-year net earnings per share trend for the last twelve months|Super X AI Corp - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months DNA (Ginkgo Bioworks Holdings)|CRNC: Quarterly EPS earnings growth|palladyneai.com (PDYN) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Veritone Inc.|MIMI: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MicroAlgo Inc. (MLGO)|Year-over-year net earnings per share growth for the last 12 months helport.ai HPAI|Quarterly EPS earnings growth LPSN (LivePerson, Inc.)|Quarterly EPS earnings growth QuickLogic Corp QUIK|System1 Group - Quarterly EPS earnings growth|Datavault AI Inc. (DVLT) - Year-over-year net earnings per share growth for the last 12 months|RYET: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Wetour (WETO)|Year-over-year net earnings per share growth for the last 12 months MCRP|Quarterly EPS earnings growth Cyanogen|Year-over-year net earnings per share growth for the last 12 months YYAI (Connexa Sports Technologies)|Year-over-year earnings per share growth rate for the last twelve months HOLO|Quarterly EPS earnings growth MSAI (MultiSensor AI Holdings)|Year-over-year net earnings per share change for the last twelve months Evaxion Biotech AS (EVAX)|Xiao-I - Quarterly EPS earnings growth|cxapp.com (CXAI) - Year-over-year net earnings per share growth for the last 12 months|BNAI: Quarterly EPS earnings growth|Gaxos.ai (GXAI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Evogene Ltd|Year-over-year earnings per share growth for the last twelve months IFBD|Year-over-year earnings per share growth for the last twelve months Taoping Inc. (TAOP)|Year-over-year net earnings per share change for the last twelve months verses.ai|Year-over-year earnings per share growth for the last twelve months Exscientia EXAI|Year-over-year earnings per one share growth for the last 12 months FOXO|VHAI: Year-over-year net earnings per share growth for the last 12 months|ZPTA (Zapata Computing Holdings) - Year-over-year earnings per share growth for the last 12 months
